Potential anti-EBV effects associated with elevated interleukin-21 levels: a case report.

Kristian Assing1, Christian Nielsen2, Marianne Jakobsen2

  • 1Department of Clinical Immunology, Odense University Hospital, J.B. Winsloevs Vej 4, 5000, Odense, Denmark. kristian.assing@rsyd.dk.

BMC Infectious Diseases
|November 24, 2020
PubMed
Summary

Elevated CD4+ T cell IL-21 levels in a patient with Epstein-Barr virus (EBV) disease may disrupt memory B cell formation, potentially aiding EBV control. This finding offers new insights into EBV pathogenesis.